These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 837367)

  • 1. Increased susceptibility of cytosol proteins to proteolytic digestion during regression of a hormone-dependent mammary tumor.
    Rouleau M; Gullino PM
    Cancer Res; 1977 Mar; 37(3):670-7. PubMed ID: 837367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arrest of synthesis of specific proteins at the onset of mammary tumor regression.
    Rouleau M; Losonczy I; Gullino PM
    Cancer Res; 1978 Apr; 38(4):926-31. PubMed ID: 639047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen-dependent in vitro stimulation of RNA synthesis in hormone-dependent mammary tumors of the rat.
    Arbogast LY; DeSombre ER
    J Natl Cancer Inst; 1975 Feb; 54(2):483-5. PubMed ID: 163335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects on insulin, prolactin, progesterone, and estradiol on DNA synthesis in organ culture of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
    Pasteels JL; Heuson JC; Heuson-Stiennon J; Legros N
    Cancer Res; 1976 Jul; 36(7 PT 1):2162-70. PubMed ID: 819126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estradiol binding in ovariectomy-responsive and -nonresponsive rat mammary carcinoma.
    Diamond EJ; Giladi M; Khan S; Hollander VP
    Cancer Res; 1977 Jun; 37(6):1852-6. PubMed ID: 870188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biological significance of estradiol receptor binding to DNA.
    Khan S; Feldman M; Hollander VP
    Cancer Res; 1980 Apr; 40(4):1050-3. PubMed ID: 7357535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone, serum, and methylxanthine interactions in the regulation of DNA synthesis in organ-cultured rat mammary tumors.
    Mayer RM; Diamond EJ; Hollander VP
    J Natl Cancer Inst; 1980 Nov; 65(5):1033-8. PubMed ID: 6159497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of hormone-dependent mammary tumors in Sprague-Dawley rats as a result of tamoxifen or pharmacologic doses of 17 beta-estradiol: cyclic adenosine 3',5'-monophosphate-mediated events.
    Bodwin JS; Hirayama PH; Rego JA; Cho-Chung YS
    J Natl Cancer Inst; 1981 Feb; 66(2):321-6. PubMed ID: 6256577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration in gene expression at the onset of hormone-dependent mammary tumor regression.
    Huang FL; Cho-Chung YS
    Cancer Res; 1983 May; 43(5):2138-42. PubMed ID: 6403232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of pituitary grafts or prolactin administrations on the hormone sensitivity of ovarian hormone-independent mouse mammary MXT tumors.
    Kiss R; de Launoit Y; Danguy A; Paridaens R; Pasteels JL
    Cancer Res; 1989 Jun; 49(11):2945-51. PubMed ID: 2720654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between the expression of estrogen-regulated genes and estrogen-stimulated proliferation of MCF-7 mammary tumor cells.
    Aitken SC; Lippman ME; Kasid A; Schoenberg DR
    Cancer Res; 1985 Jun; 45(6):2608-15. PubMed ID: 3986799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin and estrogen binding in transplantable hormone-dependent and autonomous rat mammary carcinoma.
    Costlow ME; Buschow RA; Richert NJ; McGuire WL
    Cancer Res; 1975 Apr; 35(4):970-4. PubMed ID: 163700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of chromatofocusing to distinguish estradiol receptor from ovarian-dependent and -independent rat mammary tumors.
    Coufalik AH; Feldman M; Platica M; Toth L; Dreiling D; Hollander VP
    Cancer Res; 1983 Nov; 43(11):5235-9. PubMed ID: 6616460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen control of cytosol progesterone receptor levels in the MT-W9B transplantable mammary tumor in the rat.
    Ip MM; Milholland RJ; Kim U; Rosen F
    J Natl Cancer Inst; 1982 Sep; 69(3):673-81. PubMed ID: 6955558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The conversion of an ovariectomy-nonresponsive to an ovariectomy-responsive mammary tumor strain.
    Diamond EJ; Koprak S; Shen SK; Hollander VP
    Cancer Res; 1976 Jan; 36(1):77-80. PubMed ID: 1248010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Origin of the increased activity of beta-glucuronidase in the soluble fraction of rat mammary tumors during ovariectomy-induced regression.
    Beem EP; Hillebrand MJ; Benckhuijsen C; Overdijk B
    Cancer Res; 1987 Aug; 47(15):3980-7. PubMed ID: 3607744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3H-thymidine incorporation into mammary carcinoma cells obtained by needle aspiration before and during endocrine therapy.
    Nordenskjöld B; Löwhagen T; Westerberg H; Zajicek J
    Acta Cytol; 1976; 20(2):137-43. PubMed ID: 1065173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of estrogen receptors in hormone-dependent and hormone-independent Grunder strain mouse mammary tumors.
    Moncharmont B; Ramp G; De Goeij CC; Sluyser M
    Cancer Res; 1991 Aug; 51(15):3843-8. PubMed ID: 1855202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of RNA synthesis during mammary tumor regression.
    Gullino PM; Cho-Chung YS; Losonczy I; Grantham FH
    Cancer Res; 1974 Apr; 34(4):751-7. PubMed ID: 4814993
    [No Abstract]   [Full Text] [Related]  

  • 20. Biochemical changes during regression and regrowth of hormone-dependent GR mouse mammary tumors.
    Schülein M; Daehnfeldt JL; Briand P
    Int J Cancer; 1976 Jan; 17(1):120-8. PubMed ID: 1248897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.